AA
FLXN

ALPS Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

ALPS Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-91,439
Closed -$1.14M – 906
2019
Q1 		$1.14M Buy
91,439
+3,952
+5% +$52.8K 0.01% 298
2018
Q4 		$990K Buy
87,487
+20,567
+31% +$322K 0.01% 306
2018
Q3 		$1.25M Buy
66,920
+12,298
+23% +$283K 0.01% 322
2018
Q2 		$1.41M Buy
54,622
+4,272
+8% +$111K 0.01% 272
2018
Q1 		$1.13M Buy
50,350
+8,751
+21% +$214K 0.01% 289
2017
Q4 		$1.04M Buy
41,599
+10,176
+32% +$249K 0.01% 257
2017
Q3 		$760K Buy
31,423
+2,757
+10% +$64.8K 0.01% 291
2017
Q2 		$580K Buy
28,666
+1,888
+7% +$39.3K ﹤0.01% 377
2017
Q1 		$721K Sell
26,778
-3,135
-10% -$64K 0.01% 252
2016
Q4 		$569K Sell
29,913
-5,171
-15% -$98.8K ﹤0.01% 304
2016
Q3 		$686K Buy
35,084
+4,783
+16% +$80.9K 0.01% 244
2016
Q2 		$453K Buy
30,301
+6,078
+25% +$76.4K ﹤0.01% 325
2016
Q1 		$223K Sell
24,223
-4,151
-15% -$50.3K ﹤0.01% 598
2015
Q4 		$547K Sell
28,374
-5,282
-16% -$91.7K 0.01% 336
2015
Q3 		$500K Buy
33,656
+12,392
+58% +$291K 0.01% 366
2015
Q2 		$465K Buy
+21,264
New +$429K ﹤0.01% 579

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

ALPS Advisors's FLXN Position: Q2 2019 in Review

ALPS Advisors sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2019, closing a stake of 91,439 shares — an estimated $1.14M sold.

ALPS Advisors first reported a position in FLXN in Q2 2015 and held it in 16 quarters. The position peaked at $1.41M in Q2 2018. 129 funds tracked by Wall St. Rank hold FLXN as of Q2 2019.

  • ALPS Advisors reported no remaining Flexion Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • ALPS Advisors sold 91,439 Flexion Therapeutics, Inc. shares in Q2 2019, an estimated $1.14M.
  • ALPS Advisors first reported a position in Flexion Therapeutics, Inc. in Q2 2015 and held it in 16 quarters.
  • ALPS Advisors's Flexion Therapeutics, Inc. position peaked at $1.41M in Q2 2018.
  • 129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2019.

Based on ALPS Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.